Nomura Holdings’s Anika Therapeutics ANIK Stock Holding History

Nomura Holdings’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-13,500	Closed	-$504K	–	1297
2020 Q2	$504K	Sell	13,500 -42,500	-76%	-$1.4M	﹤0.01%	869
2020 Q1	$1.62M	Buy	56,000 +45,500	+433%	+$1.84M	0.01%	507
2019 Q4	$545K	Buy	+10,500	New	+$610K	﹤0.01%	899
2019 Q2	–	Sell	-52,000	Closed	-$1.58M	–	1093
2019 Q1	$1.58M	Buy	+52,000	New	+$1.78M	0.01%	713
2014 Q3	–	Sell	-11,856	Closed	-$550K	–	2750
2014 Q2	$550K	Buy	+11,856	New	+$527K	﹤0.01%	1729

Other funds holding ANIK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

Nomura Holdings's ANIK Position: Q3 2020 in Review

Nomura Holdings sold out of Anika Therapeutics (ANIK) in Q3 2020, closing a stake of 13,500 shares — an estimated $504K sold.

Nomura Holdings first reported a position in ANIK in Q2 2014 and held it in 5 quarters. The position peaked at $1.62M in Q1 2020. 156 funds tracked by Wall St. Rank hold ANIK as of Q3 2020.

Nomura Holdings reported no remaining Anika Therapeutics position as of Q3 2020 after selling out during the quarter.
Nomura Holdings sold 13,500 Anika Therapeutics shares in Q3 2020, an estimated $504K.
Nomura Holdings first reported a position in Anika Therapeutics in Q2 2014 and held it in 5 quarters.
Nomura Holdings's Anika Therapeutics position peaked at $1.62M in Q1 2020.
156 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2020.

Based on Nomura Holdings's 13F filing for Q3 2020, filed 12 Nov 2020.